Silvercrest Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Silvercrest Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,173,365	Closed	-$4.93M	–	905
2020 Q4	$4.93M	Buy	1,173,365 +213,881	+22%	+$824K	0.04%	365
2020 Q3	$3.58M	Sell	959,484 -18,278	-2%	-$77.8K	0.03%	389
2020 Q2	$4.26M	Sell	977,762 -16,986	-2%	-$76.3K	0.04%	353
2020 Q1	$3.77M	Sell	994,748 -2,064	-0.2%	-$10.1K	0.04%	326
2019 Q4	$6.3M	Sell	996,812 -367,578	-27%	-$2.16M	0.05%	296
2019 Q3	$5.74M	Buy	+1,364,390	New	+$5.83M	0.05%	301

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silvercrest Asset Management's BDSI Position: Q1 2021 in Review

Silvercrest Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 1,173,365 shares — an estimated $4.93M sold.

Silvercrest Asset Management first reported a position in BDSI in Q3 2019 and held it in 6 quarters. The position peaked at $6.3M in Q4 2019. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

Silvercrest Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
Silvercrest Asset Management sold 1,173,365 BioDelivery Sciences International, Inc. shares in Q1 2021, an estimated $4.93M.
Silvercrest Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 6 quarters.
Silvercrest Asset Management's BioDelivery Sciences International, Inc. position peaked at $6.3M in Q4 2019.
151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on Silvercrest Asset Management's 13F filing for Q1 2021, filed 17 May 2021.